Deregulation of the Wnt/APC/β-catenin signaling is an important consequence of the APC tumor suppressor gene dysfunction. Genetic and molecular data have established the importance of this pathway in the development of colorectal cancer.
INTRODUCTION
The Wnt pathway is one of the major pathways deregulated in colorectal cancer. In the normal physiological gut, activation of this pathway ensures the proliferation of precursor cells and the renewal of the intestinal epithelium by activating the transcriptional properties of the T cell factor/lymphoid enhancer factor-1 family (1).
Stimulation by Wnt ligands leads to the stabilization of the transcription co-activator β-catenin, which becomes associated with TCFs in the nucleus, leading to the expression of specific target genes. Canonical Wnt signaling operates by regulating the phosphorylation and degradation of β-catenin (2) . Without stimulation by Wnt ligands, the levels of β-catenin in the cytoplasm are normally regulated by a multiprotein destruction complex that targets for degradation. This complex is assembled over the scaffold component Axin which contains binding domains for β-catenin, the tumor suppressor adenomatous polyposis coli (APC) and glycogen synthase kinase-3 (GSK3) and casein kinase 1 (CSNK1). Within the Axin complex, β-catenin is sequentially phosphorylated by CSNK1 and GSK3 and then degraded by the proteasome (3) . Thereby, this complex controls the proliferation of intestinal epithelial cells by maintaining the pool of active β-catenin. However, mutations of the APC gene, which were first identified in patients suffering from familial adenomatous polyposis (FAP), occur in a high proportion of sporadic colorectal carcinomas (up to 80%) (4) . Stimulation of the Wnt pathway due to a mutation in the negative regulator APC provokes the hyperproliferation of the epithelium. Several mouse models have been generated and for instance, the Apc ∆14/+ mice in which exon 14 has been deleted (frameshift mutation at codon 580) present a FAP phenotype with tumors in the distal colon and rectum, showing that heterozygous disruption of the Apc gene was associated with the accumulation of β-catenin and overexpression of the β-catenin target genes : Cyclin D1 and c-Myc (5).
The transcription cofactor RIP140 (receptor interacting protein, 140 kDa), also known as NRIP1 (nuclear receptor-interacting protein 1), was first identified in human cancer cells through its interaction with estrogen receptor α (6). RIP140 was also shown to interact with many other nuclear receptors and transcription factors (for a review see (7)). More recently, we demonstrated that RIP140 also behaves as an Rb-like regulator of the E2F pathway by directly binding to E2Fs and repressing their transactivation potentials (8) . RIP140 mainly acts as a transcriptional repressor by means of four inhibitory domains that recruit histone deacetylases or C-terminal binding proteins (9) . Several post-translational modifications, such as sumoylation and acetylation, also play important roles in controlling the subcellular location and repressive activity of RIP140 (for a review (10) ). RIP140 is a ubiquitously expressed gene whose transcription is finely regulated at the transcriptional levels both by nuclear receptors and E2Fs (11) . The physiological importance of RIP140 has been evaluated using mice that lack the Rip140 gene (RIPKO mice). These animals are viable but display a wide range of phenotypic alterations in various tissues and organs such as infertility of female mice (12) or reduced body fat content (13) , and, more recently, severe cognitive impairments (14) and mammary gland morphogenesis (15) .
Our present results demonstrate the role of RIP140 in homeostasis and tumorigenesis of the intestinal epithelium. We used mice with a loss or gain of RIP140 function to show that RIP140 inhibits cell proliferation and apoptosis in the 
RESULTS

RIP140 expression in the intestinal epithelium
Previous data indicated that RIP140 is a ubiquitously expressed transcription factor (16) . By RT-qPCR analysis, the Rip140 (Nrip1) mRNA was detected in all the mouse tissues tested and particularly, in the intestine and colon (Supplementary Figure 1A) .
We first analyzed the distribution of RIP140 in the intestinal epithelium of wild-type mice by immunofluorescence. We found that RIP140 was expressed in the nucleus of all epithelial intestinal cells, with a clearly increasing gradient along the crypt-villus axis ( Figure 1A ). To confirm this observation, we applied sequential isolation of wildtype mouse small intestinal epithelial cells. To verify the enrichment of the different fractions in villus-associated or crypt-associated cells, we quantified the mRNA levels of the Lysozyme (Lyz) and Mucin 2 (Muc2) genes, which are respectively differentiation markers of Paneth cells located in the crypts and goblet cells in the villi (17) . As expected, the Lyz gene was exclusively expressed in cells from fraction 4 whereas the Muc2 gene was mainly expressed in cells from fractions 1 and 2 ( Figure   1B ). Using the same enriched fractions, we found that the expression of Rip140 mRNA was significantly higher in differentiated cells of the villi than in cells from the crypts ( Figure 1B ).
RIP140 alters small intestine homeostasis
To study the role of RIP140 in the intestinal epithelium, we used Rip140 null (RIPKO)
or RIP140 transgenic (RIPTg) mice. In these two mouse models, the respective deletion and overexpression of the Rip140 gene in intestinal sections were validated by immunofluorescence (Supplementary Figure 1B) . As expected, the RIP140 protein was undetectable in the RIPKO mice and overexpressed in the nuclei of all intestinal epithelial cells in the RIPTg mice as compared to their wild-type littermates. RTqPCR analysis confirmed that RIPKO mice expressed β-galactosidase as a marker of the mouse Rip140 gene disruption (12) and that the transgenic human RIP140
gene was specifically expressed in RIPTg mice (Supplementary Figure 1C) .
Qualitative histopathological analysis of paraffin sections stained with hematoxylin and eosin demonstrated no gross morphological changes in the structures of the intestinal epithelia of the two mouse models ( Figure 1C, left panel) . However, precise measurements of villus and crypt lengths demonstrated statistically significant differences between transgenic and wild-type animals ( Figure 1C , right panel).
Indeed, when compared to wild-type animals, the length of the crypt-villus axis increased in Rip140 null mice and decreased in mice overexpressing RIP140. This was associated with an altered total length of the small intestine which was shorter in 
RIP140 inhibits cell proliferation and apoptosis
To determine whether cell proliferation was regulated by RIP140 expression, mice were injected with 5-ethynyl-2'-deoxyuridine (EdU) 2 hours prior sacrifice. As shown in Figure 2A , the analysis of EdU labeling demonstrated that the number of cells synthesizing DNA was significantly increased (2.6-fold) in RIPKO mice as compared to wild-type animals. By contrast, the level of EdU staining decreased (3.7-fold) in RIPTg mice as compared to control mice. These results were strengthened by quantifying the mRNAs corresponding to Myc and Pcna (proliferating cell nuclear antigen) genes (Supplementary Figure 2A) . The corresponding mRNA levels were increased up to 2-fold in RIPKO mice and decreased by up to 3-fold in the RIPTg strain as compared to wild-type animals. The differences in the expression of the Pcna gene among the three genotypes were confirmed by immunofluorescence labeling (Supplementary Figure 2B) . We next assessed the effect of RIP140 expression on apoptosis by TUNEL assay on intestinal sections. The top of the villi showed a significant 3-fold increase in TUNEL-positive cells in Rip140 null mice as compared to wild-type littermates, whereas villi overexpressing RIP140 (RIPTg)
showed a clear 2-fold decrease in apoptosis ( Figure 2B ). Altogether, these observations suggest that RIP140 regulates both cell proliferation and apoptosis and may therefore inhibit the renewal of the intestinal epithelium.
RIP140 inhibits the response of the intestinal epithelium to irradiation
To highlight the role of RIP140 in the homeostasis of the intestinal mucosa, RIPKO
and RIPTg mice together with their wild-type littermates were exposed to a single 12
Gy whole body irradiation (WBI). At day 2.5, a time when recovery is initiated, we assessed the number and length of villi, together with the length of crypts after hematoxylin-eosin staining of intestinal paraffin sections ( Figure 2C ). Following WBI, Rip140 null mice exhibited a significant increase number of regenerating villi as compared to wild-type animals. The length of villi and crypts was also significantly higher in RIPKO animals. As shown in Supplementary Figure 2C , this effect was associated with a strong rise in PCNA staining in the crypts where progenitors and stem cells reside and suggested a role for RIP140 in ionizing radiation-induced cell proliferation. As expected, this process was much slower in RIPTg mice ( Figure 2C) which exhibited only few buds of villi and weak PCNA staining of crypt cells 2.5 days after WBI (Supplementary Figure 2C) . Altogether, these results strongly indicate that RIP140 inhibits the renewal of the intestinal epithelium.
RIP140 controls β β β β-catenin activation
The Wnt/APC/β-catenin signaling is the major pathway regulating cellular homeostasis of the intestinal epithelium (18) . To decipher the underlying mechanisms involved in the effect of RIP140 in intestinal epithelium homeostasis, we sought to establish whether its expression impacted the Wnt/APC/β-catenin signaling pathway.
We first investigated the pattern of β-catenin expression and activity in the intestinal epithelia of the different mutant mice ( Figure 3A) . Immunolabeling of paraffin sections of small intestine from Rip140 null and transgenic mice revealed no significant differences in the levels of total β-catenin ( Figure 3A , left panel). We then measured the level of active β-catenin (which represents only a small fraction of total β-catenin (19)) using a specific antibody for the protein dephosphorylated on Ser37 or Thr41.
Quantification of active β-catenin (ABC) staining revealed a clear regulation by RIP140 with an increase by 2-fold in RIPKO mice and a decrease by about 3-fold in RIPTg mice as compared to controls ( Figure 3A , right panel). In order to validate the regulation of β-catenin activation by RIP140, we evaluated β-catenin transcriptional activity in intestinal epithelium by quantifying the mRNA levels of several target genes. As shown in Figure 3B , we observed a significant regulation of most of these Figure 3) , thus strengthening the negative regulation of the Wnt signaling pathway by RIP140.
RIP140 positively regulates Apc gene expression
The levels of active β-catenin is normally controlled by a multiprotein degradation complex composed of APC, AXIN1 and 2, GSK3β, CSNK1 and PP2A (18) . We therefore postulated that RIP140 could control the level of β-catenin activation by influencing the expression of members of this degradation complex. To test this hypothesis, we quantified the mRNAs encoded by the main genes implicated in β-catenin degradation. Interestingly, we found a correlation between the expression of the Rip140 gene and the mRNA levels of Apc, Axin2 and Csk1E genes which were decreased and increased in Rip140 null and transgenic mice, respectively ( Figure   3C ). This suggests that RIP140 inhibits β-catenin activation in the intestinal epithelium by positively regulating the expression of several members of the β-catenin degradation complex. Altogether, this inhibition of the β-catenin signaling pathway could explain, at least in part, the above-described effects of RIP140 on intestinal homeostasis.
RIP140 inhibits proliferation of human colon cancer cells
Given the critical role played by the Wnt/APC/β-catenin pathway in promoting colon tumorigenesis, we then investigated the role of RIP140 in human colon cancer cells. Altogether, these results demonstrated a clear inhibition of the Wnt/APC/β-catenin signaling pathway by RIP140. As shown in Supplementary Figure 4D , the impact of RIP140 has been assessed on twelve Wnt target genes both in mouse gut and in human colon cancer cells, a majority of these genes (more than 60% and 80%, respectively) being regulated by RIP140.
RIP140 increases transcription of the APC gene in human colon cancer cells
We then quantified the expression of members of the β-catenin degradation complex in the stable HCT116 clones overexpressing or not RIP140. As shown in Figure 6A, we found that the level of the APC tumor suppressor gene was significantly upregulated about 2-fold in HCT116 cells overexpressing RIP140. The specific deregulation of APC mRNA levels (2-fold decrease) was also observed after siRNAmediated depletion of RIP140 expression in RKO cells ( Figure 6B ). Very few studies have examined the regulation of APC gene transcription. However, characterization of the proximal promoter region of the human APC gene identified functional consensus binding sites for several transcription factors including p53, USF1/2 and Sp1 ( (26)(27) and Figure 6C) . In order to demonstrate the transcriptional regulation of the APC gene by RIP140, we transiently transfected HCT116 colon cancer cells with two reporter constructs containing the APC gene proximal promoter region (encompassing sequences of 972bp and 186bp, respectively) fused to the luciferase coding sequence. As shown in Figure 6C , we observed a clear induction of luciferase activity upon cotransfection with a RIP140 expression vector, indicating that RIP140 was able to transactivate the APC gene promoter. This effect was specific since control reporter vectors used in parallel were not affected by RIP140 overexpression ( Figure 6C and (28)).
Chromatin immunoprecipitation (ChIP) experiments were set up to demonstrate the presence of RIP140 on the proximal region of the APC promoter. PCR were performed in parallel on the proximal human APC promoter corresponding to the sequence which conferred the regulation by RIP140 in the luciferase assays, on an upstream region (control) and on the CCNE2 promoter (both used as negative controls). As shown in Figure 6D , we found significant amplifications of all three regions after anti-histone H3 ChIP. By contrast, a specific recruitment of RIP140 (as compared to the use of an irrelevant antibody only) was detected on the APC promoter thus identifying the APC gene as a direct transcriptional target of RIP140.
In order to demonstrate that the regulation of APC was indeed required for the regulation of β-activation by RIP140, we used HCT116 cells with APC overexpression or depletion which was assessed by quantification of the APC mRNA levels ( Figure 6E ) which led to a regulation of ABC staining mainly after ectopic expression of APC ( Figure 6F ). Very interestingly, the inhibition of ABC staining by RIP140 was lost when APC expression was modulated ( Figure 6G ) indicating that RIP140 activity was dependent of APC gene regulation.
To further support the role of APC in RIP140 activity in colon cancer cells, we used SW480 cells which expressed a mutated form of APC (29) Figure 5D ).
Decreased expression of the RIP140 gene in human colon cancers
To determine the biological relevance of our results in human pathology, we first quantified RIP140 gene expression in human colon cancer samples as compared to normal colon tissues. We first reanalyzed the published Affymetrix DNA microarray data for 17 normal tissues and 22 colon cancers (30) . As shown in Figure 7A , results clearly showed a significant decrease of RIP140 mRNA levels in colon cancer biopsies. We confirmed these findings by RT-qPCR analysis of 24 pairs of normal and tumor colon tissue samples showing a decrease of RIP140 expression in almost 60% of the tumors ( Figure 7B ).
In order to emphasize the decreased expression of the RIP140 gene in colon cancer,
we performed an immunohistochemical analysis using an anti-RIP140 antibody on a tissue microarray (TMA) containing 24 adenocarcinoma samples matched with the corresponding normal tissues. As observed at the mRNA level, we noticed a significant decrease of nuclear RIP140 positive cells in 60% of the colon adenocarcinoma as compared to the normal tissues ( Figure 7C ).
We also searched for a correlation between RIP140 and APC gene expression in human colon biopsies. In perfect agreement with the data from mice and human colon cancer cell lines, the reanalysis of a transcriptomic study performed in a cohort of 396 colon cancers (31) revealed a very significant positive correlation between the expression of the two genes at the mRNA level ( Figure 7D ). We also assessed the correlation between APC and RIP140 expression in a subset of tumors with microsatellite instability which exhibit fewer losses or gains of chromosomal regions (32) . In these tumors, the direct regulation of APC gene transcription by RIP140
should lead to a stronger correlation of their mRNA levels since no LOH in chromosome 5q would affect APC gene expression. As shown in Supplementary Figure 7D ). Altogether, these data clearly demonstrated that colon tumorigenesis is associated with a decrease in RIP140 expression both at the mRNA and protein levels which is inversely correlated with the activation of the Wnt signaling.
RIP140 expression as a prognostic marker in colon cancer
The results obtained in colon cancer cells and in patients led us to look for a link between RIP140 expression and colon cancer prognosis. As a first approach to demonstrate that low RIP140 expression in colon cancer could be associated with a shorter survival, we used the RIPKO mouse model bred with the tumor-prone Apc ∆14/+ mouse strain (5). These mice bear a germline invalidation of the Apc gene due to deletion of exon 14 which mimics human familial adenomatous polyposis (FAP) by the severity of colon tumorigenesis. In this Apc-invalidated background, the loss of one Rip140 allele strongly affected the lifespan of these mice. As shown in Figure 8A , Kaplan-Meier plots revealed that mice heterozygous for both the Apc and Rip140 genes died earlier than Apc ∆14/+ mice bearing the wild-type Rip140 gene.
These mouse experiments thus strongly supported the hypothesis that RIP140 expression could be associated with survival in colon cancer patients.
In support of this hypothesis, using the same set of tumors as in Figure 7A , we found that patients with high RIP140 mRNA levels in the tumor presented better rates of overall survival than patients with low RIP140 mRNA levels ( Figure 8B ). RIP140 expression was also found significantly correlated with progression free survival in two independent cohorts (Supplementary Figure 7A and B) . Moreover, as shown in Figure 8C , data obtained from labeling of a TMA containing 59 adenocarcinoma samples indicated that overall survival rates were higher in patients bearing tumors with a high RIP140 expression than those with tumors expressing low levels of RIP140. Altogether, these results demonstrate that RIP140 expression decreases during colon tumorigenesis and is associated with poor patient survival.
DISCUSSION
In the present study, we demonstrate that the transcriptional repressor RIP140 is involved in the regulation of intestinal epithelium homeostasis and tumorigenesis.
Based on in vivo experiments using transgenic mice, our study first identified RIP140
as a new regulator of intestinal epithelium homeostasis through its significant impact on cell proliferation and apoptosis. Indeed, using both gain and loss-of-function approaches, our data reveal that RIP140 strongly inhibits cell proliferation and programmed cell death in the intestinal epithelium. Our data also demonstrated that RIP140 plays an important role in colon cancer cells inhibiting cell cycle progression and cell proliferation in vitro and in vivo after grafting onto nude mice.
Our work clearly demonstrates that RIP140 acts as a new inhibitor of the Wnt signaling pathway through the regulation of β-catenin activation (see Figure 8D ). However, other nuclear signaling pathways targeted by RIP140 such as nuclear receptors (7) and E2Fs (8) could mediate some of the effects that we observed. Table S1 ). Targeted ES cells were injected into C57BL/6-derived blastocysts that were then transplanted into the uteri of recipient females. Resulting chimeric males were bred with C57BL/6 females, and the F1 agouti female off-springs were backcrossed with C57BL/6 males. Animals were genotyped by qPCR using RIP140 primers. The tumor-prone Apc 
Real-time quantitative PCR (RT-qPCR).
Total RNA was extracted from cells or mouse tissues using High Pure RNA Isolation kit (Roche Applied Science) according to the manufacturer's instructions. Sequential isolation of wild-type mouse small intestinal epithelial cells was performed as described (46) . Total RNA (1µg) was subjected to reverse-transcription using Superscript II reverse transcriptase (Invitrogen). RT-qPCR were performed with the LightCycler® 480 SYBR Green I Master (Roche Applied Science) and were carried out in a final volume of 10µl using 0.25µl of each primer (25µM), 5µl of the supplied enzyme mix, 2.5µl of H2O and 2µl of the template diluted at 1:10. After pre-incubation at 95°C, runs corresponded to 35 cycles of 15s each at 95°C, 5s at 60°C and 15s at 72°C. Melting curves of the PCR products were analyzed using the LightCycler® software to exclude amplification of unspecific products. Results were normalized to RS9 or 28S housekeeping gene transcripts. See Supplemental Table S1 for primer sequences. Patients who died without progression were censored at the time of death. Overall Survival (OS) was calculated from the start of palliative chemotherapy until death.
Patients lost to follow-up were censored at the time of last contact. The Kaplan-Meier method was used to estimate PFS and OS. The log-rank test was used to test the differences between groups which were considered statistically significant at the p<0.05 level. STATA statistical software (STATA, College Station, TX) was used for all analyses. 
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+/-genotype and 6 mice for the Apc +/+ and Apc ∆14/+ genotypes. B) Kaplan-Meier plots of overall survival of patients with tumors exhibiting low or high RIP140 mRNA expression. C) RIP140 immunochemistry of a tissue microarray containing adenocarcinomas of 59 patients. Patients were ranked according to RIP140 expression in the tumor and divided into two groups exhibiting low and high RIP140 expression, respectively. A Kaplan-Meier plot of the cumulative survival of patients with low or high RIP140 gene expression was performed. A log-rank test was used for statistical analysis. D) Schematic diagram picturing out the role of RIP140 on the β-catenin signaling in human colon cancer cells. RIP140 directly increases APC gene expression which inhibits activation of β-catenin (RIP140 reduces the levels of the unphosphorylated form of β-catenin). As a consequence of the drop in active β-catenin levels, RIP140 inhibits Wnt target gene expression and decreases the ability of human colon cancer cell to proliferate and form tumor in nude mice.
